Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METFORMIN\SITAGLIPTIN Cause Affect lability? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Affect lability have been filed in association with METFORMIN\SITAGLIPTIN. This represents 0.1% of all adverse event reports for METFORMIN\SITAGLIPTIN.

5
Reports of Affect lability with METFORMIN\SITAGLIPTIN
0.1%
of all METFORMIN\SITAGLIPTIN reports
0
Deaths
5
Hospitalizations

How Dangerous Is Affect lability From METFORMIN\SITAGLIPTIN?

Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.

Is Affect lability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METFORMIN\SITAGLIPTIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does METFORMIN\SITAGLIPTIN Cause?

Blood glucose increased (709) Acute kidney injury (616) Lactic acidosis (557) No adverse event (539) Diarrhoea (513) Inappropriate schedule of drug administration (469) Product dose omission issue (452) Pancreatic carcinoma (431) Drug ineffective (384) Nausea (378)

What Other Drugs Cause Affect lability?

DULOXETINE (2,510) METFORMIN (291) AMLODIPINE (274) METHOTREXATE (266) ATORVASTATIN (259) IRBESARTAN (257) LEVOTHYROXINE (251) SITAGLIPTIN (244) ESOMEPRAZOLE (234) ASPIRIN (224)

Which METFORMIN\SITAGLIPTIN Alternatives Have Lower Affect lability Risk?

METFORMIN\SITAGLIPTIN vs METFORMIN\VILDAGLIPTIN METFORMIN\SITAGLIPTIN vs METHADONE METFORMIN\SITAGLIPTIN vs METHAMPHETAMINE METFORMIN\SITAGLIPTIN vs METHENAMINE HIPPURATE METFORMIN\SITAGLIPTIN vs METHIMAZOLE

Related Pages

METFORMIN\SITAGLIPTIN Full Profile All Affect lability Reports All Drugs Causing Affect lability METFORMIN\SITAGLIPTIN Demographics